Drug Database
Back to search

Norway· NO-ID_8092AB49-BE11-43BA-A737-74007B378FE9

Kengrexal

A cangrelor product containing cangrelor tetrasodium, registered in Norway by Chiesi Farmaceutici S.p.a.. The same ATC class is registered in 13 of our 19 countries.

ATC B01AC25

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedKengrexalATCB01AC25REGISTER NO.NO-ID_8092AB49-BE11-4…PACKS LISTED3CHECKEDSeptember 25, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about cangrelor tetrasodiumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Cangrelor is registered in 13 of 19 countries.

Countries holding a registration under ATC B01AC25 (cangrelor), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 9 of them publish a price we can compare per daily dose
Search cangrelor products by name

Cangrelor · ATC B01AC25

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FEST (Norway)
Active substance
Cangrelor Tetrasodium
Manufacturer
Chiesi Farmaceutici S.p.a.
Country
Norway (NO)
ATC code
B01AC25
ATC class
Cangrelor
Defined daily dose
50 mg, P
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 3

1 priced
  • no_merkevare_id
    ID_8092AB49-BE11-43BA-A737-74007B378FE9
  • no_varenummer
    125981
    10 x 50
    NOK 41327.3
  • gtin
    7046261259811

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

135 interactions on record for cangrelor.

Graded by severity as the source publishes them — 65 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check cangrelor against other medicinesHow interaction checks work

Cangrelor · interactions on record

135 records

  • 65 severe
  • 70 moderate

Most severe, free to view

  • DicoumarolB01AA01severe
  • WarfarinB01AA03severe
  • HeparinB01AB01severe
  • Antithrombin IIIB01AB02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cangrelor in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cangrelor products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Iceland · Kengrexal
  • Liechtenstein · Kengrexal

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/df9abf33-6dd4-4553-bf24-783c053b1381
GET /v1/drugs/df9abf33-6dd4-4553-bf24-783c053b1381?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Pulver til konsentrat til injeksjons-/infusjonsvæske, oppløsning",
  "source": "fest",
  "status": "A",
  "atc_name": "Kangrelor",
  "merkevare_id": "ID_8092AB49-BE11-43BA-A737-74007B378FE9",
  "name_form_strength": "Kengrexal pulver til konsentrat til injeksjons-/infusjonsvæske, oppløsning 50 mg",
  "prescription_group": "C"
}
API referenceMCP serverPlans

See everything about cangrelor.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console